In the ALL-derived cell line REH, overexpression of PKCα was found to suppress mitochondrial protein phosphatase 2A (PP2A) activity while promote chemotherapy resistance against the drug etoposide16. The gene discussed is PRKCA; the disease is acute lymphoblastic leukemia.